Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00226174 · ClinicalTrials.gov registry record · Phase 2
A Randomized, Placebo-controlled, Double-blind Clinical Trial of Curcuminoids in Oral Lichen Planus
A Phase 2 study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- Phase 2
- Development phase
NCT00226174: Clinical Trial Phase 2 study, sponsored by University of California, San Francisco.
NCT00226174 is a Phase 2 study that was terminated before completion, run by University of California, San Francisco. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00226174, a Phase 2 study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to determine whether curcuminoids are effective in the treatment of oral lichen planus.
Interventions
- DRUG Curcuminoids
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-02 |
| Est. Completion | 2004-09 |
| Phase | Phase 2 |
Why NCT00226174 stopped before completion
NCT00226174 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Curcuminoids is the first listed.
NCT00226174 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00226174 about?
NCT00226174 is a clinical study titled "A Randomized, Placebo-controlled, Double-blind Clinical Trial of Curcuminoids in Oral Lichen Planus". The purpose of this study is to determine whether curcuminoids are effective in the treatment of oral lichen planus.
What is the current status of trial NCT00226174?
This trial is currently terminated. It is a Phase 2 study. The study started on 2003-02. Estimated completion is 2004-09.
What interventions are being tested in trial NCT00226174?
The interventions under investigation include: Curcuminoids (DRUG).
Who is sponsoring clinical trial NCT00226174?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia